Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline

Author： Mystakidou Kyriaki   Katsouda Emmanuela   Parpa Efi   Kelekis Alexis   Galanos Antonis   Vlahos Lambros  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.22, Iss.2, 2005-06, pp. : 195-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoledronic acid in lung cancer with bone metastases: a review

By Isla Dolores   Afonso Ruth   Bosch-Barrera Joaquim   Martínez Natividad  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 421-426

Informa Healthcare

Access to resources Recommend Favorite

Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

By Ripamonti Carla  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1177-1184

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?

By Vassiliou Vassilios   Kalogeropoulou Christine   Petsas Theodoros   Leotsinidis Michael   Kardamakis Dimitrios  

Clinical and Experimental Metastasis, Vol. 24, Iss. 1, 2007-03 ,pp. : 49-56

Springer Publishing Company

Access to resources Recommend Favorite

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance

By Zhao Xinmin  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 733-743

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients with painful bone metastases

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 226-230

Spandidos Publications

Access to resources Recommend Favorite